← Insider buys
ARPO

Aerpio Pharmaceuticals, Inc.

Novartis Bioventures Ltd sold $52K of Aerpio Pharmaceuticals, Inc.

10% owner

Sold$52,163
$1.02Price
51,057Shares
−1%Stake

What ARPO did after the filing

Prices for ARPO after this filing aren't in yet.

Traded Mon, Apr 22. Filed Wed, Apr 24, 3:03 PM ET, during the session. Not investment advice.